Henry Schein has announced plans to replace its Executive Management Committee with a new Henry Schein Leadership Team (HSLT) and to integrate its global supply chain organization with its global distribution group as part of a revised leadership structure. According to the company, the changes are intended to support its strategic priorities, accelerate execution, and enhance collaboration across the enterprise.
“I am pleased to announce a new leadership structure at Henry Schein that reflects an important evolution of our organization designed to help Henry Schein become simpler, prioritize and make decisions faster, better execute on our priorities, and become an even more customer-centric organization,” said Fred Lowery, chief executive officer.
“By bringing our supply chain teams closer to the customers served by our distribution businesses and enabling direct management of our corporate functions, these changes will further expedite prioritization, accelerate decision making, and advance efforts to simplify our operating model. Taken together, these changes will continue helping improve our Company and position Henry Schein for even greater success,” Mr. Lowery continued.
The company also announced that Michael S. Ettinger, executive vice president and chief operating officer, Mark E. Mlotek, executive vice president and chief strategy officer, and James ("Jim") Mullins, senior vice president, global supply chain, will transition from their current roles effective October 30, 2026. They will remain in their positions until that date and then continue with the company as senior advisors.
Commenting on the transitions, Mr. Lowery said, “Over their decades with Henry Schein, the wide-ranging impact made by Michael, Mark, and Jim upon our Company, the healthcare industry, and patient health globally is impossible to quantify. Through his strategic vision and forging of partnerships over 30+ years, Mark played an integral role in growing Henry Schein from a small, privately held mostly dental mail-order company into a multi-billion dollar public company that is the world’s largest provider of health care products, services, and technology platforms to office-based health care professionals. Similarly, I want to recognize Michael and Jim for helping build Henry Schein’s global corporate, legal, and supply chain infrastructure and, together, developing a world class team that today stands as a true competitive advantage. In their new senior advisory roles, we are fortunate to continue benefiting from their invaluable experience, insights, and strategic guidance as we execute our strategy and position the Company for continued success.”
William K. (“Dan”) Daniel, chairman of the board of directors for Henry Schein, said, “Henry Schein owes a debt of gratitude to Michael, Mark, and Jim for the significant impact of their contributions to Henry Schein’s growth across more than 100 years of combined experience with the Company, during which they have each served as pillars for the organization whose unique vision, dedication, and authentic reflection of Henry Schein’s values helped to create the tremendous platform upon which we continue to build.”
Philip A. Laskawy, director and former lead director of the board of directors from 2012 through May 2026, commented on Mr. Mlotek’s 30 years of service on the board and Mr. Ettinger’s work as liaison to the board and corporate secretary, stating, “their outstanding judgment, strategic perspective, and unwavering dedication have made an extraordinary impact upon Henry Schein. It was a privilege to serve alongside Mark on the Board, and we are deeply grateful to Mark and Michael for their enduring contributions to our Board, the Company’s leadership team, and our stakeholders.”
Mr. Lowery also shared a message sent to Team Schein members: “Each of Michael, Mark, and Jim fully embody the best of our Team Schein Values, and have poured love, passion, and joy into their every initiative and interaction. I am particularly grateful to Michael and Mark for their instrumental support in my own onboarding process. On behalf of Team Schein, we thank Michael, Mark, and Jim for their exceptional leadership, partnership, and immeasurable contributions over the years.”
Henry Schein provides products, services, and technology platforms for healthcare customers, serving more than 1 million customers worldwide through a network of more than 25,000 Team Schein members. The company supports office-based dental and medical practices, dental laboratories, government and institutional healthcare clinics, and other care settings through business, clinical, technology, and supply chain solutions. Henry Schein operates a centralized and automated distribution network with a selection of more than 300,000 branded and corporate-brand products. In 2025, the company reported sales of $13.2 billion and has operations or affiliates in 34 countries and territories.
